(2E)-1-(3',4',5'-trimethoxyphenyl)-3-(4-nitrophenyl)-2-propen-1-one | 127034-11-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (2E)-1-(3',4',5'-trimethoxyphenyl)-3-(4-nitrophenyl)-2-propen-1-one
• 英文别名: (E)-3-(4-nitrophenyl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one；1-(3,4,5-trimethoxyphenyl)-3-(4-nitrophenyl)prop-2-en-1-one；4-nitro-3',4',5'-trimethoxychalcone
• CAS: 127034-11-1
• 化学式: C₁₈H₁₇NO₆
• 分子量: 343.336
• InChiKey: PGLMCDFGQNAYCR-RMKNXTFCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  90.6
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  (2E)-1-(3',4',5'-trimethoxyphenyl)-3-(4-nitrophenyl)-2-propen-1-one 在 palladium on activated charcoal 氢气 、 双氧水 、 potassium carbonate 、 对甲苯磺酸 、 一水合肼 作用下， 以 四氢呋喃 、 甲醇 、 水 、 xylene 为溶剂， 反应 10.0h， 生成 4-[5-(3,4,5-Trimethoxy-phenyl)-2H-pyrazol-3-yl]-phenylamine
  参考文献：
  名称：

  Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins

  摘要：

  Twenty-six epoxide and corresponding pyrazole derivatives, of the structurally related chalcones and combretastatin A-4 (CA-4), were synthesized and tested for in vitro cytotoxicity. These molecules were synthesized by epoxidation of the relevant chalcones, followed by reaction with hydrazine. The structures of epoxides 3 and 7, and pyrazole 17, were confirmed by X-ray diffraction studies. The relatively coplanar conformation of a 3',3",4',4",5',5"-hexamethoxypyrazole 17 was in good agreement with the shape for 3',3",4',4",5'-pentamethoxypyrazole 16, which was determined from molecular mechanics optimization. In vitro cytotoxicity of each class of compounds was obtained using a 72 h continuous exposure MTT assay against two murine cancer cell lines; B16 melanoma and L1210 leukemia. The effect of substitution in the A-ring is addressed: three methoxy groups versus two, generally increased cytotoxicity across both cell lines. In the majority of cases, the pyrazoles are generally more active than the epoxides, with the most active, 5-(3"-amino-4"-methoxyphenyl)-3-(3',4',5'-trimethoxyphenyl)pyrazole 21, possessing an IC50 value of 5 and 2.4 mu M (B16 and L1210, respectively). Due to their planar conformations, the pyrazoles are typically less active than the corresponding chalcones, which adopt angular conformations similar to CA-4. B-ring modifications confirmed that in general the amino compounds are more active than the corresponding nitro compounds. Varying the number and orientation of methoxy groups on the A-ring did not produce any significant differences in toxicity in the cell lines studied. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2005.06.028
• 作为产物：
  描述：

  3',4',5'-三甲氧基苯乙酮 、 对硝基苯甲醛 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 反应 18.0h， 生成 (2E)-1-(3',4',5'-trimethoxyphenyl)-3-(4-nitrophenyl)-2-propen-1-one
  参考文献：
  名称：

  杂化α-溴丙烯酰胺查耳酮。设计、合成和生物学评价

  摘要：

  查尔酮抗肿瘤特性的研究在过去几年中受到了极大的关注 两个新的大型系列 α-溴丙烯酰氨基查尔酮1a - m和2a - k在其结构中包含一对迈克尔受体，对应于 α-溴丙烯酰合成部分和查尔酮框架的 α,β-不饱和酮系统，并评估其对五种癌细胞系的抗增殖活性。与相应的氨基查耳酮相比，这种杂化衍生物表现出显着增加的抗肿瘤活性。最有前途的先导分子是1k , 1m和2j 。，对五种细胞系的活性最高。K562 细胞的流式细胞术显示，活性最强的化合物导致大部分细胞进入凋亡亚 G0-G1 峰。此外，化合物1k通过线粒体途径诱导细胞凋亡并激活 caspase-3。

  DOI：

  10.1016/j.bmcl.2009.02.038

文献信息

• [EN] NUCLEAR RECEPTOR MODULATORS AND THEIR USE FOR THE TREATMENT AND PREVENTION OF CANCER<br/>[FR] MODULATEURS DE RÉCEPTEURS NUCLÉAIRES ET LEUR UTILISATION POUR LE TRAITEMENT ET LA PRÉVENTION D'UN CANCER
  申请人：US HEALTH

  公开号：WO2012174436A1

  公开（公告）日：2012-12-20

  Disclosed are compounds which are nuclear receptor modulators that can act as antagonists to the androgen receptor, for example, a compound of Formula I: wherein R1 to R5 and X1 to X5 are as described herein, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof. Pharmaceutical compositions comprising such compounds, as well as methods of use, and treatment for cancers, including prostate cancers, other nuclear receptor mediated cancers, and other conditions, are also disclosed.

  本文披露了一些化合物，它们是核受体调节剂，可以作为雄激素受体的拮抗剂，例如，公式I的化合物：其中R1至R5和X1至X5如本文所述，以及其药用盐、溶剂化合物和立体异构体。还披露了包括这些化合物的药物组合物，以及使用方法和治疗癌症，包括前列腺癌、其他核受体介导的癌症和其他疾病的方法。
• Synthesis and biological evaluation of 3′,4′,5′-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation
  作者：Yerra Koteswara Rao、Shih-Hua Fang、Yew-Min Tzeng

  DOI：10.1016/j.bmc.2009.10.022

  日期：2009.12

  anti-proliferative compound in the series with IC50 values of 1.8 and 2.2 μM toward liver cancer Hep G2 and colon cancer Colon 205 cell lines, respectively. 2,3,3′,4′,5′-Pentamethoxychalcone (1), 3,3′,4,4′,5,5′-hexamethoxychalcone (3), 2,3′,4,4′,5,5′-hexamethoxychalcone (5), 2-hydroxy-3,3′,4′,5′-tetramethoxychalcone (10), 11 and 14 showed significant anti-proliferation actions in Hep G2 and Colon 205

  合成了一系列23 3'，4'，5'-三甲氧基查耳酮类似物，它们对LPS /IFN-γ处理的巨噬细胞中一氧化氮（NO）的抑制作用，并研究了肿瘤细胞的增殖。4-羟基-3,3'，4'，5'-四甲氧基查尔酮（7），3,4-二羟基-3'，4'，5'-三甲氧基查尔酮（11），3-羟基-3'，4,4 '，5'-四甲氧基查耳酮（14）和3,3'，4'，5'-四甲氧基查耳酮（15）是产生NO最有效的生长抑制剂，IC 50值为0.3、1.5、1.3和0.3分别为μM。肿瘤细胞增殖测定结果表明，几种化合物对不同的癌细胞系表现出有效的抑制活性。查尔酮15是该系列中最有效的抗增殖化合物，对肝癌Hep G2和结肠癌Colon 205细胞系的IC 50值分别为1.8和2.2μM。2,3,3'，4'，5'-五甲氧基查耳酮（1），3,3'，4,4'，5,5'-六甲氧基查耳酮（3），2,3'，4,4'，5， 5'-六甲氧基查耳酮（5），2-羟基-3
• Hybrid α-bromoacryloylamido chalcones. Design, synthesis and biological evaluation
  作者：Romeo Romagnoli、Pier Giovanni Baraldi、Maria Dora Carrion、Olga Cruz-Lopez、Carlota Lopez Cara、Jan Balzarini、Ernest Hamel、Alessandro Canella、Enrica Fabbri、Roberto Gambari、Giuseppe Basso、Giampietro Viola

  DOI：10.1016/j.bmcl.2009.02.038

  日期：2009.4

  against five cancer cell lines. Such hybrid derivatives demonstrated significantly increased anti-tumor activity compared with the corresponding amino chalcones. The most promising lead molecules were 1k, 1m and 2j, which had the highest activity toward the five cell lines. Flow cytometry with K562 cells showed that the most active compounds resulted in a large proportion of the cells entering in the apoptotic

  查尔酮抗肿瘤特性的研究在过去几年中受到了极大的关注 两个新的大型系列 α-溴丙烯酰氨基查尔酮1a - m和2a - k在其结构中包含一对迈克尔受体，对应于 α-溴丙烯酰合成部分和查尔酮框架的 α,β-不饱和酮系统，并评估其对五种癌细胞系的抗增殖活性。与相应的氨基查耳酮相比，这种杂化衍生物表现出显着增加的抗肿瘤活性。最有前途的先导分子是1k , 1m和2j 。，对五种细胞系的活性最高。K562 细胞的流式细胞术显示，活性最强的化合物导致大部分细胞进入凋亡亚 G0-G1 峰。此外，化合物1k通过线粒体途径诱导细胞凋亡并激活 caspase-3。
• SYNTHESIS AND CYTOTOXIC PROPERTIES OF NITRO- AND AMINOCHALCONES
  作者：Hari N. Pati、Herman L. Holt、Regan LeBlanc、John Dickson、Michelle Stewart、Toni Brown、Moses Lee

  DOI：10.1007/s00044-004-0122-7

  日期：2005.1

  Twenty-two nitro- and aminochalcones were synthesized and characterized. Their cytotoxic properties were determined by a 3-day continuous exposure MTT assay with murine melanoma B16 cells. The aminochalcones were generally more cytotoxic than their nitro precursors. Aminochalcone 18, which has an IC50 value of 0.24 μM, was the most potent compound. The results demonstrated that the number and position

  合成并表征了22个硝基和氨基查耳酮。通过用鼠黑素瘤B16细胞进行3天连续暴露MTT测定来确定它们的细胞毒性特性。氨基查耳酮通常比其硝基前体更具细胞毒性。IC50值为0.24μM的氨基查耳酮18是最有效的化合物。结果表明，环A中甲氧基的数量和位置增强了查耳酮的细胞毒性。B环上氨基的位置也影响细胞毒性。
• Chalcones: a new class of antimitotic agents
  作者：Michael L. Edwards、David M. Stemerick、Prasad S. Sunkara

  DOI：10.1021/jm00169a021

  日期：1990.7

  A series of chalcones was evaluated as antimitotic agents. One of these, (E)-1-(2,5-dimethoxyphenyl)-3-[4-(dimethylamino)phenyl]-2-methyl-2-pr open- 1-one) (73), was found to be an effective antimitotic agent at a concentration of 4 nM in an in vitro HeLa cell test system. When evaluated in experimental tumor models in vivo, this compound exhibited antitumor activity against L1210 leukemia and B16 melanoma.